Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy‐Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo
Pediatric Discovery · 04.08.2026
DOI: 10.1002/pdi3.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Discovery, online erschienen am 04.08.2026. Verfasst von Hao You und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University National Clinical Research Center for Children and Adolescent…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glucocorticoid insensitivity affects a subset of asthma patients, yet its mechanism is unclear. Given the key role of airway epithelium in asthma, this study hypothesized that glucocorticoids may impair this barrier. We examined whether glucocorticoid‐induced autophagy‐associated apoptosis contributes to reduced treatment efficacy. Using an ovalbumin‐induced asthma model in BALB/c mice and 16HBE human bronchial epithelial cells treated with dexamethasone and/or autophagy inhibitor EACC (C 13 H 11 N 3 O 6 S 2 ), we assessed cell viability and apoptosis via CCK‐8 and TUNEL assays, respectively. Apoptosis and autophagy markers were analyzed by quantitative polymerase chain reaction (PCR) and western blot. Dexamethasone alleviated airway inflammation but worsened epithelial integrity in asthmatic mice. It failed to downregulate pro‐apoptotic factors while reducing anti‐apoptotic factors both in vivo and in vitro. Dexamethasone decreased 16HBE cell viability and increased apoptosis. Mechanistically, dexamethasone upregulated autophagy markers and suppressed anti‐autophagy factors in mouse lungs and cells, concurrently reducing the phosphorylation of negative regulators of autophagy. Importantly, the autophagy inhibitor EACC enhanced cell viability and attenuated dexamethasone‐induced apoptotic signaling in 16HBE cells. These findings suggest glucocorticoids may compromise the airway epithelial barrier via autophagy‐associated apoptosis in vitro and in vivo, indicating autophagy inhibition as a potential hypothesis for future therapeutic exploration for glucocorticoid‐insensitive asthma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University National Clinical Research Center for Children and Adolescents' Health and Diseases Ministry of Education Key Laboratory of Child D…
- Department of Pediatric Respiratory Medicine Chengdu Women's and Children's Central Hospital School of Medicine University of Electronic Science and Technology of China Chengdu Sichuan China.
- Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity Chongqing China.
- Key Laboratory of Children's Important Organ Development and Diseases of Chongqing Municipal Health Commission Chongqing China.
ORCID-Profile: Wenjing Zou, Tangqiaochu Gan, Ting Wang, Zhou Fu, Chao Niu
Zitieren
APA
You, H., Zou, W., Gan, T., Zhao, Y., Hu, J., Tan, W., Wang, T., Ren, L., Luo, Z., Fu, Z., & Niu, C. (2026). Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy‐Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo. Pediatric Discovery. https://doi.org/10.1002/pdi3.70060
Vancouver
You H, Zou W, Gan T, Zhao Y, Hu J, Tan W, et al. Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy‐Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo. Pediatric Discovery. 2026. doi:10.1002/pdi3.70060
BibTeX
@article{You2026,
author = {You, Hao and Zou, Wenjing and Gan, Tangqiaochu and Zhao, Yu and Hu, Jie and Tan, Wen and Wang, Ting and Ren, Luo and Luo, Zhengxiu and Fu, Zhou and Niu, Chao},
title = {Glucocorticoids Impair the Airway Epithelial Barrier via Autophagy‐Associated Apoptosis in Asthma: A Preliminary Study Both In Vitro and In Vivo},
journal = {Pediatric Discovery},
year = {2026},
doi = {10.1002/pdi3.70060}
}
EUVIMED